Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$396.1M
+47.0% from 2023
Prescriptions
403K
$982.00 per claim
Patients
88K
28,805 prescribers
Total spending, 2024
$396.3M
$4,492.82 per patient
Medicare prescription drug plans paid $396.1M for Kerendia in 2024, for 403,370 prescriptions and refills to 88,171 patients (up 47.0% from 2023). The average cost per claim was $982.00.
California had the highest Medicare cost for Kerendia in 2024: $75.8M for 83,726 claims, followed by New York ($42.8M).
Wei Y Sun, nephrology in New York, NY, had the highest Medicare cost for Kerendia in 2024: 3,330 claims costing $2.4M.
Kerendia is made by Bayer Aktiengesellschaft (BAYN.DE), listed in the Medicare spending data as Bayer,Pharm Div.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Wei Y Sun New York, NY | Nephrology | 3,330 | 519 | $2.4M |
| Jeffrey N Feldman Union, NJ | Nephrology | 782 | 196 | $1.1M |
| Elizabeth Liang Flushing, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 9,152 | 84,094 | 25,923 | $74.1M |
| 2023 | 20,329 | 271,026 | 63,592 | $269.6M |
| 2024 | 28,805 | 403,370 | 88,171 | $396.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nephrology |
| 1,093 |
| 178 |
| $814K |
| 1710074026 | Internal Medicine | 708 | 142 | $707K |
| James V Tran Westminster, CA | Internal Medicine | 566 | 129 | $627K |
| Nhan T Luu Galion, OH | Nephrology | 696 | 146 | $621K |
| Ahmet B Ergin Port St Lucie, FL | Endocrinology | 521 | 140 | $620K |
| Victor G Carabello Los Angeles, CA | Internal Medicine | 894 | 141 | $597K |
| Ankush Gulati Lehigh Acres, FL | Nephrology | 413 | 115 | $583K |
| Eliscer Guzman New York, NY | Internal Medicine | 551 | 143 | $568K |
| Geraldo A Saavedra Whitehall, PA | Endocrinology | 413 | 94 | $560K |
| Enrique J Griego McAllen, TX | Family Practice | 432 | 141 | $534K |
| Yiling Huang Elmhurst, NY | Internal Medicine | 675 | 104 | $532K |
| David G Whaley Jr. Sumter, SC | Family Practice | 668 | 103 | $517K |
| Kevin M Pargeter Chillicothe, OH | Nephrology | 609 | 106 | $496K |
| Eldrid A Baez Matos Dallas, TX | Nephrology | 426 | 105 | $477K |
| Oscar L Chien San Gabriel, CA | Internal Medicine | 639 | 83 | $474K |
| Fatima B Cintron-Rosa Humacao, PR | Nephrology | 578 | 100 | $457K |
| Luis R Garcia-Mayol Coral Gables, FL | Nephrology | 483 | 96 | $446K |
| Daniel J Castro Pereira Tucson, AZ | Nephrology | 319 | 86 | $432K |
| Subramaniam Anandasivam Brownsville, TX | Nephrology | 310 | 92 | $429K |
| Yili Huang Elmhurst, NY | Cardiology | 426 | 145 | $424K |
| Karla I Menjivar Los Angeles, CA | Nurse Practitioner | 669 | 101 | $424K |
| Sergio Chang Figueroa Madisonville, KY | Endocrinology | 411 | 86 | $422K |
| Alexander D Doan San Jose, CA | Nephrology | 344 | 81 | $422K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bayer,Pharm Div BAYN.DE | 403,577 | $396.3M |